Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 30, 2000 - Issue 2
Submit an article Journal homepage
40
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Fenamates and the potent inhibition of human liver phenol sulphotransferase

M. Vietri Department of Neurosciences, Section of Pharmacology,Medical School, Via Roma 55, I-56126 Pisa, Italy
,
C. De Santi Department of Neurosciences, Section of Pharmacology,Medical School, Via Roma 55, I-56126 Pisa, Italy
,
A. Pietrabissa Department of Neurosciences, Section of Pharmacology,Medical School, Via Roma 55, I-56126 Pisa, Italy
,
F. Mosca Department of Neurosciences, Section of Pharmacology,Medical School, Via Roma 55, I-56126 Pisa, Italy
&
G. M. Pacifici Department of Neurosciences, Section of Pharmacology,Medical School, Via Roma 55, I-56126 Pisa, Italy
Pages 111-116 | Published online: 22 Sep 2008

References

  • ANDERSON, R. J. and WEINSHILBOUM, R. M., 1980, Phenolsulphotransferase in human tissue: radio-chemical enzymatic assay and biochemical properties. Clinica et Chimica Acta, 103, 79–90.
  • ANON., 1998, Drug Data Handbook, 3rd edn (Auckland: ADIS), pp. 6–48.
  • BONHAM CARTER, S. M., REIN, G., GLOVER, V. and SANDLER, M., 1983, Human platelet phenol-sulphotransferase M and P: substrate specificities and correlation with in vivo sulphoconjugation of paracetamol and salicylamide. British Journal of Clinical Pharmacology, 15, 323–330.
  • BONNAR, J. and SHEPPARD B. L., 1996, Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. British Medical Journal, 313, 579–582.
  • CAMPBELL, N. R. C., VAN LOON, J. A. and WEllvsnmsoum, R. M., 1987, Human liver phenol sulphotransferase: assay conditions, biochemical properties and partial purification of isoenzymes of the thermostable form. Biochemical Pharmacology, 36, 1435–1446.
  • CAPP1ELLO, M., GIULIANI, L. and PACIFICI, G. M., 1990, Differential distribution of phenol and catechol sulphotransfera se in human liver and intestinal mucosa. Pharmacology, 40, 69–76.
  • CONROY, M. C., RANDINITIS, E. J. and TURNER, J. L., 1991, Pharmacology, pharmacokinetics, and therapeutic use of meclofenamate sodium. Clinical Journal of Pain, 7 (suppl. 1), S44–48.
  • FOLDES, A. and MEEK, J., 1973, Rat brain phenolsulphotransferase-partial purification and some properties. Biochimica et Biophysica Acta, 327, 365–374.
  • HOUIN, G., TREMBLAY, D., BREE, F., DUFOUR, A., LEDUDAL, P. and TILLEMENT J. P., 1983, The pharmacokinetics and availability of niflumic acid in humans. International Journal of Clinical Pharmacology, Therapy and Toxicology, 21, 130–134.
  • INsEL, P. A., 1996, Analgesic—antipyretic and antiinflammatory agents and drug employed in the treatment of gout. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon and A. Goodman Gilman (eds), The Pharmacological Basis of Therapeutics, 9th edn (New York: McGraw-Hill), pp. 617–659.
  • LENTJES, E. G. and VAN GINNEKEN, C. A., 1987, Pharmacokinetics of flufenamic acid in man. International Journal of Pharmacology, Therapy and Toxicology, 25, 185–187.
  • LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. and RANDALL, R. J., 1951, Protein measurement with Folin phenol reagent. Journal Biological Chemistry, 193, 265–275.
  • MULDER, G. J. and JAKOBY, W. B., 1990, Sulfation. In G. J. Mulder (ed.), Conjugation Reactions in Drug Metabolism (New York: Taylor & Francis), pp. 107–161.
  • NEUVONEN, P. J. and KIVISTO, K. T., 1988, Effect of magnesium hydroxide on the absorption of tolfenamic and mefenamic acids. European Journal of Clinical Pharmacology, 35, 495–501.
  • PACIFICI, G. M. and DE SAN1T C., 1995, Human sulphotransfera se. Classification and metabolic profile of the major isoforms. The point of view of the clinical pharmacologist. In G. M. Pacifici and G. N. Fracchia (eds), Advances in Drug Metabolism in Man (Luxembourg: European Commission), pp. 311–349.
  • PAC1FICI, G. M. and VIANI, A., 1992, Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences. Clinical Pharmacokinetics, 23, 449–468.
  • RAFTOGIANIS, R. B., HER, C. and WONSH1LBOUM, R. M., 1996, Human phenol sulphotransferase pharmacogenetics : STP1* gene cloning and structural characterisation. Pharmacogenetics, 6, 473–487.
  • WEllvsnmsoum, R. M., 1986, Phenol sulphotransferaw in humans: properties, regulation, and function. Federation Proceedings, 45, 2223–2228.
  • WEllvsnmsoum, R. M. and OT1ERNESS, D. M., 1994, Sulfotransferase enzymes. In: F. C. Kauffman (ed.), Conjugation—Deconjugation Reactions in Drug Metabolism and Toxicity. Handbook of Experimental Pharmacology Series, Volume 112 (Berlin: Springer), pp. 45–78.
  • ZHANG, W. Y. and Li WAN Po, A., 1998, Efficacy of minor analgesics in primary dysmenorrhoea: a systematic review. British Journal of Obstetrics and Gynaecology, 105, 780–789.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.